Analyst firms · BTIG · NEO

BTIG NEO price target and rating history

NeoGenomics Inc. (NEO) · Health Care

BTIG rates NeoGenomics Inc. (NEO) Buy with a $28 price target, as of its latest action on Oct 6, 2026. It has published 4 rating actions on NEO since May 2023, including 2 upgrades and 1 downgrade.

Current rating
Buy
Price target
$28
Median target, all firms
Too few
Actions on NEO
4

BTIG price target on NEO

$28$25$21202420252026
BTIG price target on NEO, each point a stated target, May 2023 to October 2026.

Every BTIG rating on NEO

How other firms rate NEO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BTIGBuy$28Oct 6, 2026
Leerink PartnersOutperform$25Apr 29, 2026

Questions about BTIG and NEO

What is BTIG's price target for NEO?
BTIG's latest stated price target for NeoGenomics Inc. (NEO) is $28, from its action on Oct 6, 2026.
What is BTIG's rating on NEO?
BTIG rates NEO Buy, a bullish rating, as of Oct 6, 2026.
When did BTIG last change its view on NEO?
On Oct 6, 2026, BTIG upgrades to Buy from Neutral, price target $28.

More NEO rating histories

All BTIG ratingsNEO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.